![Rao S. Bezwada](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rao S. Bezwada
Vorstandsvorsitzender bei Bezwada Biomedical LLC
Ursprung des Netzwerks ersten Grades von Rao S. Bezwada
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Orthocon, Inc.
![]() Orthocon, Inc. Medical SpecialtiesHealth Technology Orthocon, Inc. designs, develops, and markets medical implantable devices. It provides implantable products designed to stop bone bleeding. The company was founded in 2005 and is headquartered in Irvington, NY.
7
| Subsidiary | Medical Specialties | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Rao S. Bezwada
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Frazier Management LLC
![]() Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor | |
INTUITIVE SURGICAL, INC. | Medical Specialties | Director/Board Member | |
Citigroup Global Markets, Inc. (Broker)
![]() Citigroup Global Markets, Inc. (Broker) Investment Banks/BrokersFinance Citigroup Global Markets, Inc. (Broker) (CGMI-Broker) is the broker/dealer division of Citigroup Global Markets, Inc., an investment bank headquartered in New York City with additional offices across the US. The firm was founded in 2004 and is a subsidiary of Citigroup Financial Products, Inc., ultimately held by Citigroup, Inc. (NYSE: C). CGMI-Broker covers all market capitalizations of the major global indices and provides macro and quantitative analysis of global markets and sector trends. Their core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis. | Investment Banks/Brokers | Analyst-Equity | |
BIOSYNTECH, INC. | Pharmaceuticals: Major | Director/Board Member | |
Proteus Digital Health, Inc.
![]() Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Proteus Digital Health, Inc. develops medicine products and therapeutic devices. It provides digital health products that collect behavioral, physiologic, and therapeutic metrics, such as medication adherence, heart rate, sleep patterns, physical activity, and stress levels into personal management tools delivered to the mobile devices of consumers. The company was founded by Andrew M. Thompson, George M. Savage, and Mark J. Zdeblick in 2001 and is headquartered in Redwood City, CA. | Pharmaceuticals: Major | Director/Board Member | |
Artemis Medical, Inc.
![]() Artemis Medical, Inc. Medical SpecialtiesHealth Technology Artemis Medical, Inc. engages in the marketing and sale of biopsy markers. The company was founded by Richard Fulton and is headquartered in Cincinnati, OH. | Medical Specialties | Director/Board Member | |
AGILE THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sopherion Therapeutics LLC
![]() Sopherion Therapeutics LLC BiotechnologyHealth Technology Sopherion Therapeutics LLC develops and commercializes anti-cancer therapies. The company was founded by Ronald H. Goldfarb and Salvatore Forenza in 2002 and is headquartered in Princeton, NJ. | Biotechnology | Director/Board Member | |
BaroSense, Inc.
![]() BaroSense, Inc. Medical SpecialtiesHealth Technology BaroSense Inc. operates as a medical device company that focuses on the research and development of minimally invasive medical devices for the treatment of obesity. The company was founded by Richard S. Stack and William N. Starling, Jr. in 2001 and is headquartered in Redwood City, CA. | Medical Specialties | Chairman | |
MERSANA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Incline Therapeutics, Inc.
![]() Incline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Incline Therapeutics, Inc. develops pharmaceutical products. The firm operates as hospital-focused specialty pharmaceutical company focused on the development of IONSYS (fentanyl iontophoretic transdermal system). The company was founded in 2009 and is headquartered in Seatle, WA. | Pharmaceuticals: Major | Chief Executive Officer | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin | |
Duke University
![]() Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree | |
Adler Group, Inc.
![]() Adler Group, Inc. Real Estate DevelopmentFinance Adler Group, Inc. provides real estate services. The private company is based in Miami, FL and has subsidiaries in the United States. | Real Estate Development | President | |
The Scripps Research Institute
![]() The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Doctorate Degree | |
Kroll LLC
![]() Kroll LLC Investment ManagersFinance Kroll LLC provides global advisory services. It offers valuation advisory; governance, risk, investigation, and disputes; kroll cyber risk, corporates finance, and compliance and regulatory consulting. The company was founded by William Duff and George Phelps in 1932 and is headquartered in New York, NY. | Investment Managers | Corporate Officer/Principal | |
Heart Technology, Inc.
![]() Heart Technology, Inc. Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., Heart Technology, Inc. is a company that manufactures coronary and arteries treatment medical devices. The company is based in Redmond, WA. The company was founded by Lewis C. Pell, David C. Auth. Heart Technology was acquired by Boston Scientific Corp. on January 02, 1996 for $500 million. | Medical Specialties | President | |
City University of New York | College/University | Undergraduate Degree | |
Purdue University | College/University | Doctorate Degree | |
Ethicon, Inc.
![]() Ethicon, Inc. Medical SpecialtiesHealth Technology Ethicon, Inc. develops and markets medical products and devices for surgery. It offers different types of services such as wound management, women's health, and cardiovascular surgery. The company was founded by George F. Merson in 1915 and is headquartered in Somerville, NJ. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Agendia NV
![]() Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Medical/Nursing Services | Director/Board Member | |
Guava Technologies, Inc.
![]() Guava Technologies, Inc. BiotechnologyHealth Technology Guava Technologies, Inc. develops, manufactures and commercializes cytometry systems for cellular analyses. Its products include Guava Personal Cell Analysis systems, Guava PCA, Guava PCA-96, and Guava EasyCyte systems. The company was founded by Goix J. Philippe in 1998 and is headquartered in Hayward, CA. | Biotechnology | Corporate Officer/Principal | |
Roche Glycart AG
![]() Roche Glycart AG Pharmaceuticals: MajorHealth Technology Roche Glycart AG discovers and develops drugs. It is active in the research and development of new potent antibody-based products for the treatment of unmet clinical needs such as cancer. It uses its proprietary set of technologies to endow therapeutic antibodies. The company has developed glycoengineering technology (GlycoMAb) to boost a natural mechanism of action of therapeutic antibodies developed to mediate target cell killing. The company was founded in 2000 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
AM-Pharma Holding BV
![]() AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
University of Hagen | College/University | Undergraduate Degree | |
ProQuest Management LLC (Canada)
![]() ProQuest Management LLC (Canada) Investment ManagersFinance Founded in 1998, ProQuest Investments Canada is a healthcare venture capital firm located in Montreal. The firm is Canadian investment arm of US-based ProQuest Investments | Investment Managers | Chief Investment Officer | |
AM-Pharma BV
![]() AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member | |
Bellevue Asset Management (Venture Capital)
![]() Bellevue Asset Management (Venture Capital) Investment ManagersFinance Bellevue Asset Management (Venture Capital) is the venture capital arm of Bellevue Asset Management AG, a subsidiary of Bellevue Group AG (SW: BBN) headquartered in Zurich, Switzerland. The firm was founded in 1993. | Investment Managers | Private Equity Investor | |
Natural Dental Implants AG
![]() Natural Dental Implants AG Medical SpecialtiesHealth Technology Natural Dental Implants AG provides dental technology products and services. The firm specialized in the development of Replicate, a non-surgical tooth replacement system designed to alternative preserve alveolar bone and adjacent teeth. It offers an alternative solutions to traditional dental implants and three unit dental bridges, with focus on three-dimensional image and impression, natural healing, and temporary and permanent crown features. The company was founded by Ruedger Rubbert and Lea Ellermeier Nesbit in 2009 and is headquartered in Berlin, Germany. | Medical Specialties | Director/Board Member | |
The University of North Carolina at Charlotte | College/University | Graduate Degree | |
Abyrx, Inc.
![]() Abyrx, Inc. Medical SpecialtiesHealth Technology Abyrx, Inc. develops, manufactures, and markets medical therapeutic devices. It offers montage, hemasorb, heamsorb plus, hemasorb apply, and absorbable hemostatic bone putty. The company was founded in 2013 and is headquartered in Irvington, NY. | Medical Specialties | Director/Board Member Chief Executive Officer Chief Operating Officer | |
Pureos Partners AG
![]() Pureos Partners AG Investment ManagersFinance Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland. | Investment Managers | Private Equity Investor | |
THE CANNABIST COMPANY HOLDINGS INC. | Pharmaceuticals: Other | Chief Executive Officer | |
eLoupes, Inc.
![]() eLoupes, Inc. Medical SpecialtiesHealth Technology eLoupes, Inc. is a computational imaging company, which engages in the provision of visualization systems for precision tasks, like brain surgery. The company was founded by Gabriel Jones, Samuel Browd, Joshua Smith, Kenneth Denman, and James Yongquistand and is headquartered in Seattle, WA. | Medical Specialties | Director/Board Member | |
Tridek-One Therapeutics SAS
![]() Tridek-One Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Tridek-One Therapeutics SAS is a French private biotechnology company founded in 2018. The company is based in Paris, France. Tridek-One's scientific founders at INSERM conducted groundbreaking research on the role of CD31 in the modulation of the immune response, which forms the basis of the company's work. The company was founded in 2019 by Giuseppina Caligiuri, Antonino Nicoletti, and the CEO is Laurence de Schoulepnikoff. | Miscellaneous Commercial Services | Director/Board Member | |
Vico Therapeutics BV
![]() Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
New York University Tandon School of Engineering
![]() New York University Tandon School of Engineering Other Consumer ServicesConsumer Services New York University Tandon School of Engineering engages in the provision of educational services focusing on science and technology. Its degrees and programs include bachelor of science, master of science, doctor of philosophy, advanced certificate programs, a bridge program to NYU Tandon, and industry partner programs. The company was founded in 1854 and is headquartered in Brooklyn, NY. | College/University | Doctorate Degree | |
Vaximm AG
![]() Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Chairman |
Statistik
International
Vereinigte Staaten | 34 |
Schweiz | 6 |
Kanada | 5 |
Niederlande | 5 |
Deutschland | 4 |
Sektoral
Health Technology | 27 |
Finance | 11 |
Consumer Services | 10 |
Commercial Services | 4 |
Health Services | 3 |
Operativ
Director/Board Member | 34 |
Corporate Officer/Principal | 11 |
President | 8 |
Chief Executive Officer | 7 |
Chairman | 7 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Alan Levy | 22 |
Klaus Breiner | 16 |
Joyce Tsang | 15 |
David Hart | 10 |
John Pacifico | 8 |
Jan N. Lessem | 7 |
Richard L. Kronenthal | 3 |
- Börse
- Insiders
- Rao S. Bezwada
- Unternehmensverbindungen